# Michelle Monje

Principales episodios de podcast
Actualizado:

How the brain helps cancers grow | Michelle Monje

Today, we're talking with Stanford neuro-oncologist, Michelle Monje. This is actually the third time we've had Michelle on the show, in part because she's been a pioneer of three exciting frontiers in neuroscience — so far!  This week, we're going to talk about cancer neuroscience. Michelle founded…

Genetics, Research, and Future Therapies for NF1 with Dr. David Gutmann

· transcripción
In this episode, my guest is Dr. David Gutmann, a leading neurologist specializing in Neurofibromatosis Type 1 (NF1). The conversation delves into Dr. Gutmann's groundbreaking research on the NF1 protein neurofibromin and its role in downregulating the RAS/RAF/MAPK cell signaling pathway. We explor…

Katerina Akassoglou: Blood Clots, Brain Inflammation, and Covid

Superimposed on an impressive body of work on the blood-brain-barrier and immune system, Prof Akassoglou and her collaborators just published an elegant study in Nature that centered on the direct binding os the SARS-CoV-2 spike protein to fibrin with marked downstream pro-inflammatory effects. Th…

593: Uncertainty to Conviction: A Stanford MD/PhD’s Journey

(00:01) Journey to Medicine (10:30) Navigating Medicine and Research Paths (27:22) Navigating Doubt and Motivation in Medicine (36:54) Embracing Doubt in Finding Direction Navigating the uncertainty of a career in medicine is no small feat, as Kamsi shares in our latest episode. From her time at St…

A Conversation with Michelle Monje

In this episode of Conversations @ the Salt Line host Wesley Dixon chats with Dr. Michelle Monje '98 who is a 2021 recipient of the MacArthur "Genius" award and the Milan Gambhir Professor of Pediatric Neuro-Oncology at Stanford University School of Medicine. Wesley and Dr. Monje discuss the inters…

Spotlight: Frank Winkler, Professor for Neuro-Oncology, Heidelberg University

Dr. Frank Winkler, at Heidelberg University focuses on the emerging field of cancer neuroscience, and the way brain cancers proceed. Winkler has used two-photon imaging to confirm that glioma cells link through microtubes, similar to typical neurons in the brain. His groundbreaking work has earned …

Ben Woodington on Coherence Bio's Revolutionary Cancer Reprogramming Approach

In this episode of the Neural Implant Podcast, we sit down with Ben Woodington, co-founder of Coherence Bio, a groundbreaking medical technology company pioneering a new frontier in cancer treatment. By integrating neurotechnology, neurobiology, and machine learning, Coherence is building a platfor…

The future of cancer neuroscience

Neurologist Michelle Monje studies the close relationship between cancer and the nervous system, particularly in an aggressive brain cancer that often strikes in childhood. Her research shows that the cancer cells are electrically integrated into the brain itself and these connections actually help…

Trailer: Welcome to alpha

You're about to hear from the women building what comes next.In cancer research and climate engineering.In AI, space exploration, public health, biotech, policy, and every room where the future is being shaped.This is alpha.A podcast about women in science, technology, engineering, and math - the f…

Why is brain cancer so hard to treat?

Brain cancers are rare, but devastating. Patients face short life expectancies after diagnosis. Brain tumors are often impossible to remove completely. And radiation and chemotherapy don’t always stop them from spreading.  It’s a daunting class of disease to study, but that didn’t dissuade physici…